In the first trial on humans, Israeli scientists have shown hyperbaric oxygen therapy (HBOT) can reduce two key biological hallmarks of aging – telomere length shortening and accumulation of senescent cells. These factors lower the risk of cancer, dementia, Alzheimer’s and much more.

https://www.prnewswire.com/il/news-releases/first-time-human-study-shows-reversal-in-biology-of-aging–telomere-shortening-and-senescent-cells-accumulation–with-hyperbaric-oxygen-therapy-hbot-301176053.html

https://www.aging-us.com/article/103571